Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–#Biocom–Biocom, the association representing the life science industry of California, issued the following statement in response to a…
WASHINGTON–(BUSINESS WIRE)–#Medicare–Today, Citizens Against Government Waste (CAGW) released the following comments regarding House Speaker Nancy Pelosi’s (D-Calif.) partisan drug pricing…
Several leaders of some of the largest pharmaceutical companies have met on Tuesday with the newly elected US president, Donald Trump to discuss industry related topics, agreeing that the talks were positive.
U.S. President Donald Trump in a meeting on Tuesday with pharmaceutical executives called on them to manufacture more of their drugs in the United States and cut prices, while vowing to speed approval of new medicines and ease regulation.
The newly appointed president of the United States of America, Donald Trump said that he wants pharmaceutical companies to manufacture their products in America, during the meeting he held with leaders of some of the major drugmakers.